Sign in

CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company

ENDRA Life Sciences Inc.

Sign in to watch
Ticker
NDRA
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
260579295
Phone
734-335-0468
Business address
3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
Former names
Endra Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-28 DIGIANDOMENICO ANTHONY Director Grant or award · Stock Options +109,323 109,323
2022-03-28 Pestrikova Irina Senior Director, Finance Grant or award · Stock Options +41,500 41,500
2022-03-28 Harsh Michael Director Grant or award · Stock Options +109,492 109,492
2022-03-28 Basenese Lou Director Grant or award · Stock Options +74,500 74,500
2022-01-03 Tokman Alexander Y Director Grant or award · Stock Options +12,000 12,000
2022-01-03 DIGIANDOMENICO ANTHONY Director Grant or award · Stock Options +12,000 12,000
2022-01-03 Harsh Michael Director Grant or award · Stock Options +12,000 12,000
2022-01-03 Basenese Lou Director Grant or award · Stock Options +12,000 12,000
2021-08-26 Basenese Lou Director Sale −5,000 $1.85 $9K 49,068
2021-08-25 Basenese Lou Director Sale −45,000 $1.83 $82K 54,068
2021-06-18 Pestrikova Irina Senior Director, Finance Grant or award · Stock Option +75,000 75,000
2021-04-07 Thornton Michael Milos Chief Technology Officer Sale −15,000 $2.53 $38K 259,960
2021-04-05 Tokman Alexander Y Director Grant or award · Stock Options +25,000 25,000
2021-04-05 Harsh Michael Director Grant or award · Stock Options +25,000 25,000
2021-04-05 DIGIANDOMENICO ANTHONY Director Grant or award · Stock Options +25,000 25,000
2021-04-05 Basenese Lou Director Grant or award · Stock Options +25,000 25,000
2021-04-05 Maloberti Renaud Bertrand Chief Commercial Officer Grant or award · Stock Options +25,000 25,000
2021-04-05 Wells David R. Chief Financial Officer Grant or award · Stock Options +25,000 25,000
2021-04-05 Thornton Michael Milos Chief Technology Officer Grant or award · Stock Options +50,000 50,000
2021-04-05 Michelon Francois Roger Chief Executive Officer Grant or award · Stock Options +50,000 50,000

Page 3 of 11 · 207 trades